Hims & Hers (NYSE: HIMS) stock dropped over 9% after COO Nader Kabbani left his position to take on a new advisory role. Mike Chi will replace him effective Nov. 2, bringing experience from executive positions in marketing and product management at companies like Zola and Intermix. Investors may be concerned about the change in leadership.

The Motley Fool Stock Advisor team did not include Hims & Hers Health in their list of the 10 best stocks for investors to buy now. The stocks that made the cut could potentially bring significant returns in the future, as seen with past recommendations like Netflix and Nvidia. Stock Advisor’s total average return is 1,063%, outperforming the S&P 500.

Investors should consider the impact of leadership changes at Hims & Hers Health before buying stock. The company’s decision to replace its COO and bring in a new executive raises concerns about consistency and stability in the C-suite. Mike Chi’s appointment may bring new perspectives, but investors typically prefer longevity in leadership roles.

Read more at Yahoo Finance: Why Hims & Hers Stock Slipped Today